ArticleDrug delivery and translational research2025

Nano-delivery of a novel inhibitor of ERCC1-XPF for targeted sensitization of colorectal cancer to platinum-based chemotherapeutics.

Parnian Mehinrad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.